Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells
2005
The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy
2008
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
2009
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
2004
Human Tumor Antigen-Specific Helper and Regulatory T Cells Share Common Epitope Specificity but Exhibit Distinct T Cell Repertoire
2010
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Imaging Ligand-Dependent Activation of CXCR7
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Dendritic cells as therapeutic vaccines against cancer
2005
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
2009
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma
2005
Control of intestinal homeostasis by regulatory T cells and dendritic cells
2007
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Regulatory T Cells
2010
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Imaging in the era of molecular oncology
2008 StandoutNature
Regulatory T Cells in Cancer
2010
Immunology and immunotherapy approaches for prostate cancer
2007
Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9
2007
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease
2010
The Human T Cell Response to Melanoma Antigens
2006
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
2009
The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells
2008
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Basic principles of tumor-associated regulatory T cell biology
2012
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Regulatory T cells and cancer
2007
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis
2006
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Toll-like receptors on regulatory T cells: expanding immune regulation
2006
Immunity, Inflammation, and Cancer
2010 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Antigens for cancer immunotherapy
2008
In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines
2006
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma
2004
Cancer immunotherapy comes of age
2011 StandoutNature
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
2017
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2
2005
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune Responses
2008
Positive and negative influences of regulatory T cells on tumour immunity
2008
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells
2005
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
2006
Cancer-related inflammation
2008 StandoutNature
CXCR3 ligands in disease and therapy
2014
Regulatory T Cells Reversibly Suppress Cytotoxic T Cell Function Independent of Effector Differentiation
2006
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
2009 StandoutNature
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
2005
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
2007
Roles of regulatory T cells in cancer immunity
2016
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
2005
Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis
2016
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
2005
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Treg functional stability and its responsiveness to the microenvironment
2014
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy
2007
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node
2005
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation
2006
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination
2006
Recent Progress in Ferroptosis Inducers for Cancer Therapy
2019
The Metabolic Underpinnings of Ferroptosis
2020
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
2007
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells
2004
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
2005
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Natural regulatory T cells: mechanisms of suppression
2007 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells
2004
Neoantigens in cancer immunotherapy
2015 StandoutScience
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Dendritic Cells Loaded with Stressed Tumor Cells Elicit Long-Lasting Protective Tumor Immunity in Mice Depleted of CD4+CD25+ Regulatory T Cells
2005
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
2005
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
2013
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Yanchun Li being referenced
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
2005 Science
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
2009
Identification of Frataxin as a regulator of ferroptosis
2020
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
2004
Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production
2005
Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis
2014
DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin
2018
Functional Characterization of EBV-Encoded Nuclear Antigen 1–Specific CD4+ Helper and Regulatory T Cells Elicited byIn vitroPeptide Stimulation
2005